Bloedverlies studie na een Aortaklep vervanging/

Bloodloss study after Aortic Valve Replacement.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27077

Enrollment

310

Registered

2012-03-27

Start date

2012-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bloodloss AVR Mecc ECC

Interventions

AVR operation with ECC. The aim of this study is to measure if there is a significant difference in bloodloss with two different heartlung machine's, comparing a MECCs ystem with a conventional ECC c

Eligibility

Inclusion criteria

Inclusion criteria: 1. Above 18 years; 2. Only AVR operation; 3. No Re-Do operation.

Exclusion criteria

Exclusion criteria: 1. Under 18 years; 2. Double operation; 3. Re-do operation; 4. No informed consent given.

Design outcomes

Secondary

Measure	Time frame
1. Numbers of bloodtransfusions; 2. Renal function 24 hours after surgery; 3. Duration of post-operative intubation; 4. Re-Sternotomy; 5. Cardiac markers after 24 hours.	—

Primary

Measure	Time frame
Post-operative bloodloss 12 hours after arriving on the ICU. This is an objective measurement with the thoracic drainsysytem.	—

Contacts

Public ContactK. Knol

Postbus 50.000

k.knol@mst.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)